Literature DB >> 21515362

Homomeric and heteromeric complexes among TGF-β and BMP receptors and their roles in signaling.

Marcelo Ehrlich1, Daniel Horbelt, Barak Marom, Petra Knaus, Yoav I Henis.   

Abstract

Transforming growth factor-β (TGF-β) ligands and bone morphogenetic proteins (BMPs) play myriad roles in many biological processes and diseases. Their pluripotent activities are subject to multiple levels of regulation, including receptor oligomerization, endocytosis, association with co-receptors, cellular scaffolds or membrane domains, as well as transcriptional control. In this review, we focus on TGF-β and BMP receptor homomeric and heteromeric complex formation and their modulation by ligand binding, which regulate signaling on a near-immediate timescale. We discuss the current structural, biochemical and biophysical evidence for the oligomerization of these receptors, and the potential roles of distinct oligomeric interactions in signaling.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21515362     DOI: 10.1016/j.cellsig.2011.04.004

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  39 in total

Review 1.  Allosteric function and dysfunction of the prion protein.

Authors:  Rafael Linden; Yraima Cordeiro; Luis Mauricio T R Lima
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

2.  Regarding the mechanism of action of a proposed peptide agonist of the bone morphogenetic protein receptor activin-like kinase 3.

Authors:  Malcolm Whitman; Vicki Rosen; Ali H Brivanlou; Jay C Groppe; Walter Sebald; Thomas Mueller
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

3.  Differential molecular regulation of processing and membrane expression of Type-I BMP receptors: implications for signaling.

Authors:  Tal Hirschhorn; Michal Levi-Hofman; Oded Danziger; Nechama I Smorodinsky; Marcelo Ehrlich
Journal:  Cell Mol Life Sci       Date:  2017-03-29       Impact factor: 9.261

Review 4.  In vitro selection technologies to enhance biomaterial functionality.

Authors:  Jonah C Rosch; Emma K Hollmann; Ethan S Lippmann
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-02

5.  Visualization of BRI1 and BAK1(SERK3) membrane receptor heterooligomers during brassinosteroid signaling.

Authors:  Christoph A Bücherl; G Wilma van Esse; Alex Kruis; Jeroen Luchtenberg; Adrie H Westphal; José Aker; Arie van Hoek; Catherine Albrecht; Jan Willem Borst; Sacco C de Vries
Journal:  Plant Physiol       Date:  2013-06-24       Impact factor: 8.340

6.  Context-dependent proangiogenic function of bone morphogenetic protein signaling is mediated by disabled homolog 2.

Authors:  Jun-Dae Kim; Hyeseon Kang; Bruno Larrivée; Min Young Lee; Marcel Mettlen; Sandra L Schmid; Beth L Roman; Yibing Qyang; Anne Eichmann; Suk-Won Jin
Journal:  Dev Cell       Date:  2012-08-14       Impact factor: 12.270

7.  The immunophilin FKBP12 inhibits hepcidin expression by binding the BMP type I receptor ALK2 in hepatocytes.

Authors:  Silvia Colucci; Alessia Pagani; Mariateresa Pettinato; Irene Artuso; Antonella Nai; Clara Camaschella; Laura Silvestri
Journal:  Blood       Date:  2017-09-01       Impact factor: 22.113

8.  Lin28 regulates BMP4 and functions with Oct4 to affect ovarian tumor microenvironment.

Authors:  Wei Ma; Jing Ma; Jie Xu; Chong Qiao; Adam Branscum; Andres Cardenas; Andre T Baron; Peter Schwartz; Nita J Maihle; Yingqun Huang
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

9.  Bone Morphogenetic Protein-2 Induces Donor-Dependent Osteogenic and Adipogenic Differentiation in Human Adipose Stem Cells.

Authors:  Sari Vanhatupa; Miina Ojansivu; Reija Autio; Miia Juntunen; Susanna Miettinen
Journal:  Stem Cells Transl Med       Date:  2015-10-22       Impact factor: 6.940

10.  The factor VII-activating protease (FSAP) enhances the activity of bone morphogenetic protein-2 (BMP-2).

Authors:  Elfie Kathrin Roedel; Elisabeth Schwarz; Sandip Madhav Kanse
Journal:  J Biol Chem       Date:  2013-01-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.